News

Filter

Current filters:

Alkeran

1 to 9 of 30 results

EC approves expanded indication for Velcade

15-09-2008

US health care major Johnson & Johnson's multiple myeloma drug Velcade (bortezomib) has been approved…

AlkeranbortezomibDeltasoneJanssen-CilagJohnson & JohnsonmelphalanPrednisoneVelcade

Millennium publishes results of VISTA trial

08-09-2008

Millennium, now a US subsidiary of Japan's Takeda, has published results from the Phase III VISTA trial…

AlkeranbortezomibDeltasonemelphalanPrednisoneVelcade

JWCI to take part in Ph III Dulcuth trial

01-09-2008

The John Wayne Cancer Institute, at Saint John's Health Center in Santa Monica, California, will take…

Alkeranmelphalan

Millennium/J&J's FDA approval for Velcade

30-06-2008

The US Food and Drug Administration has given approval to Velcade (bortezomib), an injection for the…

AlkeranAmino AcidsbortezomibDeltasoneInjectionJohnson & JohnsonmelphalanNystatinOralPhysostigmine SalicylatePrednisoneVelcade

Celgene posts 1st-qtr loss on Pharmion costs

19-05-2008

US drugmaker Celgene reported a loss in first-quarter 2008 of $1.64 billion, $3.98 per share, versus…

AlkeranDexmethylphenidate HydrochlorideFocalinlenalidomidemelphalanMethylphenidate HclRevlimidRitalinThalidomideThalomid

1 to 9 of 30 results

COMPANY SPOTLIGHT

Menarini

Back to top